Publication:
Liver X receptor activation inhibits SGLT2-mediated glucose transport in human renal proximal tubular cells

dc.contributor.authorPattira Chonlaketen_US
dc.contributor.authorTeerasak Wongwanen_US
dc.contributor.authorSunhapas Soodvilaien_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2019-08-23T10:37:25Z
dc.date.available2019-08-23T10:37:25Z
dc.date.issued2018-02-01en_US
dc.description.abstract© 2017 The Authors. Experimental Physiology © 2017 The Physiological Society New Findings: What is the central question of this study? The liver X receptor (LXR) has been reported to regulate several membrane transporters. It is imperative to investigate whether LXR activation regulates SGLT2-mediated glucose transport in human renal proximal tubular cells. What is the main finding and its importance? Liver X receptor activation inhibits SGLT2 transport function in normal and high-glucose conditions via reduction of SGLT2 protein expression. Liver X receptors (LXRs) are members of a nuclear receptor family consisting of two isoforms, LXRα and LXRβ. They play a major role in energy metabolism, including lipid and glucose metabolism. Recent studies reported that LXRs regulate plasma glucose, although the mechanism is still uncertain. The present study investigated whether LXR activation regulates sodium glucose cotransporter2 (SGLT2) in human renal proximal tubular cells. LXR agonists, T0901317 and GW3965, inhibited SGLT2-mediated glucose uptake in a concentration-dependent manner. The effect of T0901317 and GW3965 was attenuated by a LXR antagonist, fenofibrate. Activation of the retinoid X receptor (RXR) agonist, bexarotene, potentiates the inhibitory effect of these ligands. Thus, the inhibitory effect of LXR agonists on SGLT2 was mediated and facilitated by LXR and RXR activation, respectively. In addition, the inhibitory effect of LXR agonists was not mediated by cytotoxicity. Exposing HK-2 cells, a renal proximal tubular cell line, to LXR agonists significantly reduced the maximal transport rate of SGLT2 without any effect on transporter affinity. Western blot analysis revealed that LXR activation significantly decreased protein expression of SGLT2 with no change in mRNA level. In addition, LXR activation inhibited canagliflozin-sensitive short-circuit current, which represents SGLT2-mediated glucose transport in a polarized human renal proximal tubular cell monolayer. Furthermore, LXR activation inhibited the transport function of SGLT2 in hyperglycaemic conditions. As such, this study represents evidence for the inhibitory effect of LXR activation on glucose transport in human renal proximal tubular cells.en_US
dc.identifier.citationExperimental Physiology. Vol.103, No.2 (2018), 250-260en_US
dc.identifier.doi10.1113/EP086478en_US
dc.identifier.issn1469445Xen_US
dc.identifier.issn09580670en_US
dc.identifier.other2-s2.0-85038628936en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/45248
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85038628936&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.titleLiver X receptor activation inhibits SGLT2-mediated glucose transport in human renal proximal tubular cellsen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85038628936&origin=inwarden_US

Files

Collections